Russian Registry for Treatment of Venous Thromboembolism Using Anticoagulants, Surgery, Thrombolysis, and Stenting

What this Trial Is About

This research focuses on patients with venous thromboembolism VTE, including deep vein thrombosis and pulmonary embolism, treated at various Russian medical centers. It aims to collect and update patient data in a digital registry to support future prospective randomized, cohort, and observational studies. The registry is managed by the Medalp Private Surgery Clinic and seeks to understand treatment outcomes and patient quality of life. Patients receive treatment through different approaches such as anticoagulants, thrombolysis, open surgery to remove blood clots, and venous stenting to relieve vein obstruction. These treatments are recorded in the registry as they are performed as part of routine care. The registry continuously collects data over time, including baseline and follow-up assessments at 3 and 12 months after procedures. Participants contribute by allowing their treatment and health data to be entered into the digital database. Researchers assess vein openness patency, postthrombotic syndrome symptoms, and quality of life using SF-36 and AVVQ questionnaires at baseline, 3 months, and 12 months after intervention. This ongoing data collection helps monitor patient outcomes and supports future research. Participation duration varies depending on treatment and follow-up schedules.

Ongoing Registry of Treatment of Venous Thromboembolism